| scholarly article | Q13442814 |
| P50 | author | Gwendalyn J. Randolph | Q88180808 |
| P2093 | author name string | Edward A Fisher | |
| Takao Shimizu | |||
| Satoshi Ishii | |||
| Véronique Angeli | |||
| Kei Satoh | |||
| Jaime Llodrá | |||
| James X Rong | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| atherosclerosis | Q12252367 | ||
| dyslipidemia | Q66291209 | ||
| P304 | page(s) | 561-574 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization | |
| P478 | volume | 21 |
| Q30371651 | 12/15-Lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and function. |
| Q44985231 | A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions? |
| Q41866270 | A major role for RCAN1 in atherosclerosis progression |
| Q33276712 | Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease |
| Q33862296 | Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes |
| Q34339759 | Aiming drug discovery at lysophosphatidic acid targets |
| Q54971987 | Anti-Inflammatory Effects of HDL in Mice With Rheumatoid Arthritis Induced by Collagen. |
| Q42373755 | Apolipoprotein A-I Modulates Atherosclerosis Through Lymphatic Vessel-Dependent Mechanisms in Mice |
| Q34285479 | Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice |
| Q37385275 | Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity |
| Q55526978 | Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study. |
| Q40311522 | Atherosclerosis progression and monocyte emigration from plaque. |
| Q37953777 | Atherosclerosis: current pathogenesis and therapeutic options |
| Q37138017 | Autoimmunity in atherosclerosis: a protective response losing control? |
| Q56689036 | Bridging the innate and adaptive immune systems |
| Q35572404 | CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice |
| Q37835548 | CCL19-CCR7-dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima |
| Q43145952 | CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis |
| Q37036080 | CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima |
| Q36392394 | Cells of the synovium in rheumatoid arthritis. Dendritic cells. |
| Q35102753 | Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report |
| Q52347151 | Chemokine and chemotactic signals in dendritic cell migration. |
| Q42562376 | Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib |
| Q36260399 | Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice |
| Q37808645 | Current advances in understanding of immunopathology of atherosclerosis |
| Q37398202 | Cutting edge: migration of langerhans dendritic cells is impaired in autoimmune dermatitis |
| Q39021691 | Dendritic cell migration in health and disease |
| Q38023274 | Dendritic cells and regulatory T cells in atherosclerosis |
| Q37748449 | Dendritic cells and their role in atherogenesis |
| Q37624571 | Dendritic cells in atherosclerosis |
| Q36108241 | Dendritic cells in atherosclerosis: current status of the problem and clinical relevance |
| Q33651897 | Dendritic cells in atherosclerotic disease |
| Q37942858 | Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques |
| Q34494245 | Dendritic cells produce inflammatory cytokines in response to bacterial products from Staphylococcus aureus-infected atopic dermatitis lesions |
| Q36284556 | Dendritic cells: tools and targets for antitumor vaccination |
| Q33989067 | Dendritic-cell trafficking to lymph nodes through lymphatic vessels |
| Q41922729 | Differential effects of a saturated and a monounsaturated fatty acid on MHC class I antigen presentation |
| Q30425368 | Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis |
| Q36229716 | Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity |
| Q46787446 | Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses |
| Q34530204 | Effects of LDL Receptor Modulation on Lymphatic Function |
| Q38330817 | Emerging trends in the pathophysiology of lymphatic contractile function |
| Q37260168 | Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis |
| Q37140855 | Exercise training improves obesity-related lymphatic dysfunction |
| Q37280859 | Extracellular vesicles are present in mouse lymph and their level differs in atherosclerosis |
| Q35889058 | Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis |
| Q33236495 | Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice |
| Q42917861 | Giant cell arteritis: dendritic cells take two T's to tango |
| Q37672264 | HDL and immunomodulation: an emerging role of HDL against atherosclerosis |
| Q33868782 | HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells |
| Q38197735 | HDL quality and functionality: what can proteins and genes predict? |
| Q26782972 | HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis |
| Q64111542 | Halted Lymphocyte Egress via Efferent Lymph Contributes to Lymph Node Hypertrophy During Hypercholesterolemia |
| Q33232238 | High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis. |
| Q36804177 | Hypercholesterolemia impairs immunity to tuberculosis |
| Q37316589 | Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration |
| Q89776597 | Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells |
| Q36228584 | Impaired Langerhans cell migration in psoriasis |
| Q28588533 | Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance? |
| Q55446683 | Inflammation, not Cholesterol, Is a Cause of Chronic Disease. |
| Q33805176 | Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics |
| Q33659705 | Innate and adaptive immunity in atherosclerosis |
| Q23912213 | Lipid accumulation and dendritic cell dysfunction in cancer |
| Q36422582 | Lipopolysaccharide modulates neutrophil recruitment and macrophage polarization on lymphatic vessels and impairs lymphatic function in rat mesentery |
| Q36242772 | Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model |
| Q53623436 | Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice. |
| Q36732040 | Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis |
| Q34036806 | Lymphatic lipid transport: sewer or subway? |
| Q38843093 | Lymphatic pumping: mechanics, mechanisms and malfunction. |
| Q30440410 | Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent |
| Q37384489 | Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR. |
| Q35597306 | MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity |
| Q33789327 | Macrophage death and defective inflammation resolution in atherosclerosis |
| Q36193752 | Macrophages, dendritic cells, and regression of atherosclerosis |
| Q37196450 | Mclk1+/- mice are not resistant to the development of atherosclerosis |
| Q37597597 | Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue |
| Q33761114 | Mechanisms that regulate macrophage burden in atherosclerosis |
| Q36145180 | Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2 |
| Q37608493 | Monocyte retention in the pathology of atherosclerosis |
| Q36093861 | Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell Formation |
| Q39144827 | Myeloid cells pave the way for lymphatic system development and maintenance |
| Q37314961 | New roles of HDL in inflammation and hematopoiesis |
| Q35608570 | Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis |
| Q37022848 | Noncanonical dendritic cell differentiation and survival driven by a bacteremic pathogen. |
| Q36852547 | Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function |
| Q47274127 | Obesity-induced lymphatic dysfunction is reversible with weight loss. |
| Q37424025 | Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36. |
| Q28384581 | Oxidized lipids block antigen cross-presentation by dendritic cells in cancer |
| Q37998021 | Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta |
| Q35849695 | Platelet depletion in mice increases mortality after thermal injury. |
| Q58905662 | Pro- and Anti-Inflammatory Cytokine Networks in Atherosclerosis |
| Q34582934 | Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. |
| Q37899798 | Progress in HDL-based therapies for atherosclerosis |
| Q41894347 | Prostaglandin E 2 Does Not Modulate CCR7 Expression and Functionality after Differentiation of Blood Monocytes into Macrophages |
| Q28392770 | Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer |
| Q37068628 | Rapid regression of atherosclerosis: insights from the clinical and experimental literature |
| Q30317889 | Recommendations for detection of individual risk for comorbidities in patients with psoriasis. |
| Q27028112 | Regression of atherosclerosis: insights from animal and clinical studies |
| Q28083961 | Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism |
| Q37080012 | Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis |
| Q37548085 | Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen |
| Q37628845 | Self-Reported Snoring Is Associated with Dyslipidemia, High Total Cholesterol, and High Low-Density Lipoprotein Cholesterol in Obesity: A Cross-Sectional Study from a Rural Area of China |
| Q28396774 | T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases |
| Q37196471 | TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis |
| Q58760917 | The Inhibitory Effect of Ojeoksan on Early and Advanced Atherosclerosis |
| Q37560012 | The Role of Immunogenicity in Cardiovascular Disease |
| Q38195893 | The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis |
| Q36508676 | The immune response in atherosclerosis: a double-edged sword |
| Q35230117 | The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients |
| Q37282249 | The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models |
| Q37339539 | The role of adaptive T cell immunity in atherosclerosis |
| Q30436606 | The role of oxidized phospholipids in atherosclerosis |
| Q37050929 | The role of the vascular dendritic cell network in atherosclerosis |
| Q27303091 | The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient mice |
| Q36072740 | Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis. |
| Q37495603 | Vaccination against atherosclerosis? Induction of atheroprotective immunity |
| Q43263819 | Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. |
Search more.